Investment Research & Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Investment Research & Advisory Group's LLY Position: Q2 2026 in Review
Investment Research & Advisory Group increased its Eli Lilly (LLY) stake by 1.2% in Q2 2026, buying an estimated $92K and bringing the position to 7,451 shares worth $8.96M. The position accounts for 2.77% of the portfolio, ranked #6.
Investment Research & Advisory Group first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 1,862 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Investment Research & Advisory Group held 7,451 shares of Eli Lilly worth $8.96M as of Q2 2026.
- Investment Research & Advisory Group bought 90 Eli Lilly shares in Q2 2026, an estimated $92K.
- Eli Lilly made up 2.77% of Investment Research & Advisory Group's portfolio in Q2 2026, its #6 holding.
- Investment Research & Advisory Group first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
- 1,862 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Investment Research & Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.